Transforming the Paradigm for Lipid Lowering

JAMA Cardiol. 2021 Dec 1;6(12):1414. doi: 10.1001/jamacardio.2021.3517.

Authors

Ann Marie Navar^{1

2}, Gregg C Fonarow^{3

4}

Affiliations

¹ Clinical Heart and Vascular Center, University of Texas Southwestern Medical Center, Dallas.
² Associate Editor, JAMA Cardiology.
³ Ahmanson-UCLA (University of California, Los Angeles) Cardiomyopathy Center, David Geffen School of Medicine, UCLA.
⁴ Section Editor, JAMA Cardiology.

PMID: 34550298
DOI: 10.1001/jamacardio.2021.3517

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Hypolipidemic Agents* / therapeutic use
Lipids*

Substances

Hypolipidemic Agents
Lipids